山东大学学报(医学版) ›› 2014, Vol. 52 ›› Issue (10): 15-19.doi: 10.6040/j.issn.1671-7554.0.2014.351
张鹏飞, 徐晓娅, 姜曼, 毕玉莉, 许继映, 韩明勇
ZHANG Pengfei, XU Xiaoya, JIANG Man, BI Yuli, XU Jiying, HAN Mingyong
摘要: 目的 探讨脂多糖(LPS)诱导肺血管生成的相关信号途径。方法 12只6~8周龄的雌性BALB/c小鼠随机分为两组,分别行腹腔注射LPS和PBS,作为LPS组(n=6)和PBS组(n=6),建立小鼠炎症模型。采用HE染色和免疫荧光实验检测肺血管密度,应用ELISA法测定血清血管内皮生长因子(VEGF)。分离正常小鼠肺血管内皮细胞(MPVECs)并培养,分别给予VEGF、PGE2、Celecoxib、EP受体拮抗剂AH6809和4种EP受体激动剂(ONO-AE1-259-01、ONO-DI-004、ONO-AE-248、ONO-AE1-329)进行刺激,观察内皮细胞成管情况,检测培养上清液中VEGF表达水平。结果 LPS诱导小鼠肺部炎症反应及血管生成;LPS组小鼠血清VEGF水平明显高于PBS组小鼠(P<0.01)。单独使用PGE2或VEGF能促进血管生成;Celecoxib可抑制VEGF诱导的肺血管生成,仅EP2受体激动剂ONO-AE1-259-01能使MPVECs上清液中VEGF水平升高(P<0.05),而EP2受体拮抗剂AH6809抑制MPVECs培养上清液中的VEGF水平(P<0.05)。结论 LPS可以诱导小鼠肺部炎症反应,并使VEGF表达水平升高;Celecoxib可抑制血管内皮细胞VEGF的表达水平。LPS通过PGE2-EP2信号通路介导,促进血管内皮细胞产生VEGF,从而促进血管生成。
中图分类号:
| [1] Ikebe M, Kitaura Y, Nakamura M, et al. Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway[J]. J Surg Oncol, 2009, 100(8):725-731. [2] He Z, Zhu Y, Jiang H. Inhibiting toll-like receptor 4 signaling ameliorates pulmonary fibrosis during acute lung injury induced by lipopolysaccharide: an experimental study[J]. Respir Res, 2009, 10: 126. [3] Valcárcel M, Mendoza L, Hernández J J, et al. Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2[J]. J Transl Med, 2011, 9: 142. [4] Zhao Y, Kong X, Li X, et al. Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells[J]. PLoS One, 2011, 6(12): e29363. doi: 10.1371/journal.pone.0029363. [5] Attar B M, George M, Ion-Nedelcu N, et al. Disease dependent qualitative and quantitative differences in the inflammatory response to ascites occurring in cirrhotics[J]. World J Hepatol, 2014, 6(2): 85-91. [6] Baeriswyl V, Christofori G. The angiogenic switch in carcinogenesis[J]. Semin Cancer Biol, 2009, 19(5): 329-337. [7] 徐晓娅, 毕玉莉, 姜曼, 等.血管内皮生长因子促进肺转移相关受体通路的研究[J].山东大学学报:医学版, 2013, 51(11): 25-29. XU Xiaoya, BI Yuli, JIANG Man, et al. Vascular endothelial growth factor (VEGF) promotes lung carcinoma metastasis via VEGFR1 in mouse model[J]. Journal of Shandong University: Health Sciences, 2013, 51(11): 25-29. [8] Ranganathan P V, Jayakumar C, Mohamed R, et al. Netrin-1 regulates the inflammatory response of neutrophils and macrophages, and suppresses ischemic acute kidney injury by inhibiting COX-2-mediated PGE2 production[J]. Kidney Int, 2013, 83(6): 1087-1098. [9] Weems Y S, Bridges P J, Jeoung M, et al. In vivo intra-luteal implants of prostaglandin (PG) E1 or E2 (PGE1, PGE2) prevent luteolysis in cows. Ⅱ: mRNA for PGF2α, EP1, EP2, EP3 (AD), EP3A, EP3B, EP3C, EP3D, and EP4 prostanoid receptors in luteal tissue[J]. Prostaglandins Other Lipid Mediat, 2012, 97(1-2): 60-65. [10] Morita Y, Morita N, Hata K, et al. Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-c and lymph node metastasis in human oral tongue cancer[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2014, 117(4): 502-510. [11] Frölich S, Olliges A, Kern N, et al. Temporal expression of the PGE2 synthetic system in the kidney is associated with the time frame of renal developmental vulnerability to cyclooxygenase-2 inhibition[J]. Am J Physiol Renal Physiol, 2012, 303(2): F209-F219. [12] Peng M, Wang Y L, Wang F F, et al. The cyclooxygenase-2 inhibitor parecoxib inhibits surgery-induced proinflammatory cytokine expression in the hippocampus in aged rats[J]. J Surg Res, 2012, 178(1): e1-e8. doi: 10.1016/j.jss.2012.08.030. [13] Zhao L, Wu Y, Xu Z, et al. Involvement of COX-2/PGE2 signalling in hypoxia-induced angiogenic response in endothelial cells[J]. J Cell Mol Med, 2012, 16(8): 1840-1855. [14] Wang X, Li G, Wang A, et al. Combined histone deacetylase and cyclooxygenase inhibition achieves enhanced antiangiogenic effects in lung cancer cells[J]. Mol Carcinog, 2013, 52(3): 218-228. [15] Nakanishi M, Sato T, Li Y, et al. Prostaglandin E2 stimulates the production of vascular endothelial growth factor through the E-prostanoid-2 receptor in cultured human lung fibroblasts[J]. Am J Respir Cell Mol Biol, 2012, 46(2): 217-223. |
| [1] | 于德新 蔡跃红 马祥兴 张晓明 李传福. 肝细胞癌血管生成及其成熟度的临床意义[J]. 山东大学学报(医学版), 2209, 47(6): 51-54. |
| [2] | 杜艾家,张曼,陈鹤,王丽新,尚应殊. 微小RNA-1270靶向调控血管生成素样蛋白7抑制巨噬细胞炎症和脂质蓄积[J]. 山东大学学报 (医学版), 2025, 63(2): 1-9. |
| [3] | 华月帆,何珂瑶,张家豪,钱梦凡,刘怡文,孔金玉,杨海军,周福有. 具核梭杆菌诱导缺氧诱导因子及血管生成因子高表达对食管鳞癌患者生存预后的影响[J]. 山东大学学报 (医学版), 2023, 61(11): 59-67. |
| [4] | 秦静,杨飞,陈谦,夏涵岱,刘延国,王秀问. 晚期驱动基因阴性、PD-L1表达阴性非鳞非小细胞肺癌一线治疗方案的网状Meta分析[J]. 山东大学学报 (医学版), 2022, 60(7): 74-82. |
| [5] | 王国云,潘臧钰. 子宫腺肌病动物模型研究进展[J]. 山东大学学报 (医学版), 2022, 60(7): 48-55. |
| [6] | 孙丽娜,杜晓晓,张红娟,孟金来. 人类白细胞抗原G调控蜕膜自然杀伤细胞促进滋养细胞侵袭[J]. 山东大学学报 (医学版), 2022, 60(6): 41-45. |
| [7] | 赵婷婷,齐亚娜,张颖,袁冰,韩明勇. 小鼠乳腺癌诱导转移前肺组织微环境的改变[J]. 山东大学学报 (医学版), 2022, 60(4): 24-29. |
| [8] | 曹义海. 血管生成在疾病治疗中的应用与展望[J]. 山东大学学报 (医学版), 2021, 59(9): 9-14. |
| [9] | 仇静静,吴婷,牟亚魁,崔丽梅,郭文涛,韩锋产,孙岩. 大鼠鼓室硬化建模优化及与纤维连接蛋白高表达的关联[J]. 山东大学学报 (医学版), 2021, 59(1): 22-27. |
| [10] | 张淑莹,武晓峰,郭丽敏,乔温,彭洁琼,李大庆. 两种阿霉素心力衰竭模型及心功能进展的评估[J]. 山东大学学报 (医学版), 2020, 58(12): 1-7. |
| [11] | 徐鹏飞,朱玲,万云焱,姚周虹,李德志,王聪,翟聪聪,李文,林殿杰. 重组人血管内皮抑素联合重组人干扰素γ对小鼠Lewis肺癌移植瘤的作用[J]. 山东大学学报 (医学版), 2020, 58(1): 1-5. |
| [12] | 张美玲,孙卉,孙文凯,孟朝暾,邬信芳,高伟,李钦. 鼻腔滴入γ干扰素对变应性鼻炎大鼠外周血Th17/Treg细胞及相关细胞因子的影响[J]. 山东大学学报 (医学版), 2020, 58(1): 13-19. |
| [13] | 刘聪聪,刘洪彬,符江,李雷. 多囊卵巢综合征易感基因dennd1a在斑马鱼模型中的表达特性[J]. 山东大学学报 (医学版), 2019, 57(1): 48-54. |
| [14] | 胡玉敬,吴大勇,张文艳,边艳珠,魏强,田丛娜,常胜利. 放疗后肿瘤99Tcm-MNLS乏氧显像变化与乏氧诱导因子-1α表达的相关性[J]. 山东大学学报(医学版), 2017, 55(8): 30-34. |
| [15] | 聂思月,王震,孙靖宇,刘杰,李娟,魏小娟,路春晓,吕兴龑,王淑云,孙玉萍. ANGPTL5在人胃癌组织中的表达及临床意义[J]. 山东大学学报(医学版), 2017, 55(8): 61-65. |
|
||